Developer docs
API playgroundTry for free, no card

Search company profiles

INTERLAB GmbH

Full company profile

uuid002j1or

Namestring
INTERLAB GmbH
Legal namestring
SGS INSTITUT FRESENIUS GmbH
Websiteurl
interlab.de
Company typeenum
Private
Founded yearint
1994
Descriptiontext

INTERLAB GmbH is identified in the firmographic block as a Munich-based independent central laboratory founded in 1994, employing 101-250 people and supporting clinical trials for pharmaceutical and biotechnology companies. However, the source material aggregated for this analysis is in fact a detailed profile of SGS INSTITUT FRESENIUS GmbH, a German private limited company headquartered in Berlin that operates within the SGS Group — one of the world's leading inspection, verification, and testing conglomerates. Given the source-material conflict, the analytical description below is grounded in the documented SGS INSTITUT FRESENIUS profile. Under that profile, the company delivers contract laboratory and analytical services across five operating pillars: Health & Nutrition (pharmaceutical clinical trial laboratory testing across Phase I-IV, drug development analytics, food and feed testing, cosmetics and hygiene testing, and TraitGenetics genotyping); Industries & Environment (PFAS, asbestos, air/water/gas analysis, hygiene diagnostics); Consumer Goods & Retail (electrical devices, toys, textiles, furniture testing); and Materials & Failure Analysis (microelectronics, battery testing, plastics and composites). Its core technology stack consists of physical laboratory analysis, chemical and physical surface analytics, GLP-compliant study execution, extractables & leachables testing, and the SGS proderm European Center of Excellence for Dermatology Research.

Revenue is generated primarily through B2B contract laboratory services on a project-based, multi-year engagement model, with pricing negotiated per scope and complexity rather than published as tiers. Secondary revenue derives from the SGS Academy training platform, which delivers domain-specific training in pharmaceutical, food safety, and adjacent sectors in classroom and online formats. Distribution is sales-led: the company engages enterprise pharmaceutical and medical device clients directly through technical sales representatives, with the broader SGS Group network providing international reach and cross-sell into adjacent testing services. Customer segmentation is vertical (pharmaceutical/biopharma and medical devices as primary; food/feed, cosmetics, and industrial as secondary), and the company sells exclusively in Europe (primarily Germany).

The company has no public pricing, no disclosed revenue figures, and no public AI or API capabilities; differentiation rests on regulatory credentials (GLP), SGS Group affiliation, and specialized expertise in dermatology clinical research via SGS proderm.

Short descriptiontext

SGS INSTITUT FRESENIUS GmbH is a German contract laboratory services provider affiliated with the global SGS Group, delivering clinical trial laboratory testing, analytical laboratory services for drug development, GLP studies, and dermatology clinical research to pharmaceutical, medical device, food, and cosmetics clients across Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMunich, Germany
HQ citystring
Munich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
central laboratory services, clinical trial testing, pharmaceutical analytics, biopharmaceutical testing, GLP-compliant studies
Industry2 codes
PRIMARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
NAICS code3 codes
  • Medical Laboratories621511
  • Testing Laboratories and Services54138
  • Medical and Diagnostic Laboratories62151
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Contract Laboratory Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Contract Laboratory Testing Services
TypeProfessional Services
Description

The company generates revenue primarily through providing contracted laboratory analysis and testing services to pharmaceutical, medical device, food, cosmetics, and chemical industry clients. Services are delivered across the drug development lifecycle from early-phase development through market launch. Revenue is project-based and recurring as clients return for additional testing needs across product lines and development stages.

sgs-institut-fresenius.de
2Training Services (SGS Academy)
TypeProfessional Services
Description

Revenue generated from professional training programs offered through the SGS Academy, providing up-to-date training in pharmaceutical, food safety, and other industry domains in classroom and online formats.

sgs-institut-fresenius.de
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1B2B contract services — quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing tiers are published. Service fees are determined by project scope, testing complexity, regulatory requirements, and volume. Clients contact the company directly for quotations.

sgs-institut-fresenius.de
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1SGS proderm
Description

European Center of Excellence for Dermatology Research providing high-quality clinical studies and reliable contract research.

sgs-institut-fresenius.de
+1 more record
Core offering1 text field

INTERLAB GmbH is an independent central laboratory that supports clinical trials for pharmaceutical and biotechnology companies. It provides analytical laboratory testing services, drug development support, and GLP-compliant study execution across clinical trial phases, primarily serving pharmaceutical and biopharmaceutical clients across all stages of drug development.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SGS INSTITUT FRESENIUS offers a comprehensive portfolio of laboratory services for the pharmaceutical and life science industries. The company's service offerings include Clinical Trial Laboratory Testing for Phase I-IV studies, Clinical Research Services through partnership with SGS CRO, SGS proderm as the European Center of Excellence for Dermatology Research, and Analytical Laboratory Services and Drug Development. These services are complemented by SGS Academy training programs. The company leverages a global network of analytical contract laboratories with skilled scientific staff to support drug development from molecule to market launch.

Product and service4 records
1Clinical Trial Laboratory Testing
CategoryClinical Trial Central Laboratory Services
Description

Central laboratory testing services supporting clinical trials across Phase I to Phase IV studies, including the various laboratory tests necessary for trial success.

2Analytical Laboratory Services and Drug Development
CategoryPharmaceutical Analytical Services
Description

Laboratory analysis of pharmaceutical products per desired requirements and regulations, test method development, and delivery of reliable, clearly documented test results for drug development.

3GLP-Compliant Studies
CategoryRegulatory Compliance Testing
Description

Good Laboratory Practice (GLP) compliant studies for the chemical and pharmaceutical industries, supporting regulatory submissions and compliance requirements.

4Clinical Research Services (CRO)
CategoryContract Research Organization (CRO) Services
Description

Clinical research services for Phase I to IV studies with focus on early development and biometrics, provided as part of a broader CRO offering for Health and Life Science.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

SGS INSTITUT FRESENIUS operates as a subsidiary or brand within the broader SGS Group, one of the world's leading inspection, verification, and testing companies. The partnership provides access to SGS's global laboratory network, corporate resources, and cross-selling opportunities across the full portfolio of testing and certification services. The SGS Group connection enables international reach and credibility for the company.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development and commercial services. Comparable on clinical research services and central lab support for Phase I–IV trials; broader commercial-services orientation differentiates it from a pure central lab operator.

TypeBroad incumbent
Description

Eurofins is a leading global testing services group with deep pharma, food, cosmetics, and environmental testing capabilities across Europe, including central lab and clinical trial support. Comparable across multiple of the subject's verticals (pharma, food, cosmetics, environmental); broader portfolio and European headquarters make it a primary competitor.

TypeBroad incumbent
Description

ICON is a top-5 global CRO providing clinical research and central laboratory services (formerly PRA Health) to pharma and biotech. Direct competitor for clinical trial central lab and Phase I–IV testing services; significantly larger scale and global lab footprint.

TypeBroad incumbent
Description

Intertek is a global quality assurance and testing company with pharma, food, and environmental testing services. Comparable across the subject's non-clinical testing lines (food, cosmetics, industrial materials); less central lab / clinical trial focus, but competes for the same regulated-industry QA/QC wallet.

TypeBroad incumbent
Description

Charles River is a major CRO offering preclinical, clinical, and manufacturing services, with central lab capabilities supporting clinical trials. Directly comparable on clinical research and central lab services for pharma/biopharma sponsors, though skewed more toward preclinical and discovery than the subject's clinical-stage focus.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO and operates a global central laboratory network (Q² Solutions) supporting Phase I–IV clinical trials with bioanalytical, genomic, and biorepository services. Directly comparable on clinical trial central lab and clinical research services; competes for the same pharma/biopharma sponsors but at meaningfully larger scale.

TypeBroad incumbent
Description

Bureau Veritas is a global testing, inspection, and certification (TIC) company with commodity, industrial, and some life-sciences testing. Comparable on the industrial/material testing side; weaker overlap on the clinical central lab and pharma testing lines that are central to the subject's offering.

TypeDirect peer
Description

Frontage is a US-headquartered CRO providing bioanalytical, CMC, and central laboratory services to pharma/biotech sponsors. Closely comparable in service mix (central lab, bioanalytical, drug development support) and target customer (small-to-mid biopharma); similar mid-sized scale, making it a relevant direct peer for benchmarking.

TypeBroad incumbent
Description

Labcorp historically operated one of the largest central lab networks supporting clinical trials globally, with Fortrea spun out to house the clinical development services business. Direct peer for clinical trial central lab services; comparable in service scope (central lab, bioanalytical, specialty testing) but substantially larger in scale and geographic reach.

TypeOthers
Description

SGS is the parent/affiliate organization of the subject entity and operates a global network of analytical and clinical laboratories. While not a direct competitor, SGS's broader testing portfolio (inspection, verification, certification) and global lab footprint are the mechanism through which the subject entity accesses international clients and cross-sell opportunities.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

INTERLAB GmbH

Contract Laboratory Servicesinterlab.de

SGS INSTITUT FRESENIUS GmbH is a German contract laboratory services provider affiliated with the global SGS Group, delivering clinical trial laboratory testing, analytical laboratory services for drug development, GLP studies, and dermatology clinical research to pharmaceutical, medical device, food, and cosmetics clients across Europe.

What INTERLAB GmbH does

INTERLAB GmbH is identified in the firmographic block as a Munich-based independent central laboratory founded in 1994, employing 101-250 people and supporting clinical trials for pharmaceutical and biotechnology companies. However, the source material aggregated for this analysis is in fact a detailed profile of SGS INSTITUT FRESENIUS GmbH, a German private limited company headquartered in Berlin that operates within the SGS Group — one of the world's leading inspection, verification, and testing conglomerates. Given the source-material conflict, the analytical description below is grounded in the documented SGS INSTITUT FRESENIUS profile. Under that profile, the company delivers contract laboratory and analytical services across five operating pillars: Health & Nutrition (pharmaceutical clinical trial laboratory testing across Phase I-IV, drug development analytics, food and feed testing, cosmetics and hygiene testing, and TraitGenetics genotyping); Industries & Environment (PFAS, asbestos, air/water/gas analysis, hygiene diagnostics); Consumer Goods & Retail (electrical devices, toys, textiles, furniture testing); and Materials & Failure Analysis (microelectronics, battery testing, plastics and composites). Its core technology stack consists of physical laboratory analysis, chemical and physical surface analytics, GLP-compliant study execution, extractables & leachables testing, and the SGS proderm European Center of Excellence for Dermatology Research.

Revenue is generated primarily through B2B contract laboratory services on a project-based, multi-year engagement model, with pricing negotiated per scope and complexity rather than published as tiers. Secondary revenue derives from the SGS Academy training platform, which delivers domain-specific training in pharmaceutical, food safety, and adjacent sectors in classroom and online formats. Distribution is sales-led: the company engages enterprise pharmaceutical and medical device clients directly through technical sales representatives, with the broader SGS Group network providing international reach and cross-sell into adjacent testing services. Customer segmentation is vertical (pharmaceutical/biopharma and medical devices as primary; food/feed, cosmetics, and industrial as secondary), and the company sells exclusively in Europe (primarily Germany).

The company has no public pricing, no disclosed revenue figures, and no public AI or API capabilities; differentiation rests on regulatory credentials (GLP), SGS Group affiliation, and specialized expertise in dermatology clinical research via SGS proderm.

INTERLAB GmbH firmographics

Firmographics
Name
INTERLAB GmbH
Legal name
SGS INSTITUT FRESENIUS GmbH
Website
https://interlab.de
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
1–10 employees
Short description
SGS INSTITUT FRESENIUS GmbH is a German contract laboratory services provider affiliated with the global SGS Group, delivering clinical trial laboratory testing, analytical laboratory services for drug development, GLP studies, and dermatology clinical research to pharmaceutical, medical device, food, and cosmetics clients across Europe.
Ownership category
akta.pro rank

INTERLAB GmbH industry classification

Industry
Product category
Contract Laboratory Services
NAICS
Medical Laboratories (621511), Testing Laboratories and Services (54138), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs

Keywords

  • Central laboratory services
  • Clinical trial testing
  • Pharmaceutical analytics
  • Biopharmaceutical testing
  • GLP-compliant studies

Where INTERLAB GmbH is headquartered

Location

Headquarters

HQ city
Munich
HQ country
Germany
HQ region
Europe

Offices4 records

Markets served

INTERLAB GmbH business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Laboratory Testing Services: The company generates revenue primarily through providing contracted laboratory analysis and testing services to pharmaceutical, medical device, food, cosmetics, and chemical industry clients. Services are delivered across the drug development lifecycle from early-phase development through market launch. Revenue is project-based and recurring as clients return for additional testing needs across product lines and development stages.
  2. Training Services (SGS Academy): Revenue generated from professional training programs offered through the SGS Academy, providing up-to-date training in pharmaceutical, food safety, and other industry domains in classroom and online formats.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B contract services — quote-based pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

INTERLAB GmbH product offering

Product offering

Core offering

INTERLAB GmbH is an independent central laboratory that supports clinical trials for pharmaceutical and biotechnology companies. It provides analytical laboratory testing services, drug development support, and GLP-compliant study execution across clinical trial phases, primarily serving pharmaceutical and biopharmaceutical clients across all stages of drug development.

Product overview

SGS INSTITUT FRESENIUS offers a comprehensive portfolio of laboratory services for the pharmaceutical and life science industries. The company's service offerings include Clinical Trial Laboratory Testing for Phase I-IV studies, Clinical Research Services through partnership with SGS CRO, SGS proderm as the European Center of Excellence for Dermatology Research, and Analytical Laboratory Services and Drug Development. These services are complemented by SGS Academy training programs. The company leverages a global network of analytical contract laboratories with skilled scientific staff to support drug development from molecule to market launch.

Differentiator

Problem solved

Functional benefit

Brands

  • SGS proderm: European Center of Excellence for Dermatology Research providing high-quality clinical studies and reliable contract research.
  • SGS Analytics

Products and services

  • Clinical Trial Laboratory Testing Central laboratory testing services supporting clinical trials across Phase I to Phase IV studies, including the various laboratory tests necessary for trial success.
  • Analytical Laboratory Services and Drug Development Laboratory analysis of pharmaceutical products per desired requirements and regulations, test method development, and delivery of reliable, clearly documented test results for drug development.
  • GLP-Compliant Studies Good Laboratory Practice (GLP) compliant studies for the chemical and pharmaceutical industries, supporting regulatory submissions and compliance requirements.
  • Clinical Research Services (CRO) Clinical research services for Phase I to IV studies with focus on early development and biometrics, provided as part of a broader CRO offering for Health and Life Science.

Companies that use INTERLAB GmbH

Customer profile

Segments5 records

Ideal customer profiles1 record

INTERLAB GmbH technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

INTERLAB GmbH partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SGS Group (Societe Generale de Surveillance)coreOthersSGS INSTITUT FRESENIUS operates as a subsidiary or brand within the broader SGS Group, one of the world's leading inspection, verification, and testing companies. The partnership provides access to SGS's global laboratory network, corporate resources, and cross-selling opportunities across the full portfolio of testing and certification services. The SGS Group connection enables international reach and credibility for the company.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

INTERLAB GmbH competitors and assessment

Company assessment

Broad incumbents

  • Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development and commercial services. Comparable on clinical research services and central lab support for Phase I–IV trials; broader commercial-services orientation differentiates it from a pure central lab operator.
  • Eurofins Scientific: Eurofins is a leading global testing services group with deep pharma, food, cosmetics, and environmental testing capabilities across Europe, including central lab and clinical trial support. Comparable across multiple of the subject's verticals (pharma, food, cosmetics, environmental); broader portfolio and European headquarters make it a primary competitor.
  • ICON plc: ICON is a top-5 global CRO providing clinical research and central laboratory services (formerly PRA Health) to pharma and biotech. Direct competitor for clinical trial central lab and Phase I–IV testing services; significantly larger scale and global lab footprint.
  • Intertek Group: Intertek is a global quality assurance and testing company with pharma, food, and environmental testing services. Comparable across the subject's non-clinical testing lines (food, cosmetics, industrial materials); less central lab / clinical trial focus, but competes for the same regulated-industry QA/QC wallet.
  • Charles River Laboratories: Charles River is a major CRO offering preclinical, clinical, and manufacturing services, with central lab capabilities supporting clinical trials. Directly comparable on clinical research and central lab services for pharma/biopharma sponsors, though skewed more toward preclinical and discovery than the subject's clinical-stage focus.
  • IQVIA Holdings: IQVIA is the world's largest CRO and operates a global central laboratory network (Q² Solutions) supporting Phase I–IV clinical trials with bioanalytical, genomic, and biorepository services. Directly comparable on clinical trial central lab and clinical research services; competes for the same pharma/biopharma sponsors but at meaningfully larger scale.
  • Bureau Veritas: Bureau Veritas is a global testing, inspection, and certification (TIC) company with commodity, industrial, and some life-sciences testing. Comparable on the industrial/material testing side; weaker overlap on the clinical central lab and pharma testing lines that are central to the subject's offering.
  • Labcorp (and Fortrea spin-out): Labcorp historically operated one of the largest central lab networks supporting clinical trials globally, with Fortrea spun out to house the clinical development services business. Direct peer for clinical trial central lab services; comparable in service scope (central lab, bioanalytical, specialty testing) but substantially larger in scale and geographic reach.

Direct peers

  • Frontage Laboratories: Frontage is a US-headquartered CRO providing bioanalytical, CMC, and central laboratory services to pharma/biotech sponsors. Closely comparable in service mix (central lab, bioanalytical, drug development support) and target customer (small-to-mid biopharma); similar mid-sized scale, making it a relevant direct peer for benchmarking.

Others

  • SGS Group: SGS is the parent/affiliate organization of the subject entity and operates a global network of analytical and clinical laboratories. While not a direct competitor, SGS's broader testing portfolio (inspection, verification, certification) and global lab footprint are the mechanism through which the subject entity accesses international clients and cross-sell opportunities.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

INTERLAB GmbH social profiles

Digital presence

INTERLAB GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

INTERLAB GmbH leadership team

Management profile

Number of profiles

INTERLAB GmbH funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

INTERLAB GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INTERLAB GmbH

What does INTERLAB GmbH do?

INTERLAB GmbH is an independent central laboratory that supports clinical trials for pharmaceutical and biotechnology companies. It provides analytical laboratory testing services, drug development support, and GLP-compliant study execution across clinical trial phases, primarily serving pharmaceutical and biopharmaceutical clients across all stages of drug development.

Is INTERLAB GmbH a public or private company?

INTERLAB GmbH is a private company. It is classified as unknown and is currently operating.

When was INTERLAB GmbH founded?

INTERLAB GmbH was founded in 1994. It employs 1 to 10 people.

Where is INTERLAB GmbH based?

INTERLAB GmbH is headquartered in Munich, Germany, in the Europe region.

How does INTERLAB GmbH make money?

Two revenue lines are on record. Contract Laboratory Testing Services are the primary driver. The others are training Services (SGS Academy).

Who are INTERLAB GmbH's main competitors?

Broad incumbents on record are Syneos Health, Eurofins Scientific, ICON plc, Intertek Group, Charles River Laboratories, IQVIA Holdings, Bureau Veritas and Labcorp (and Fortrea spin-out). Frontage Laboratories is listed as a direct peer. SGS Group is listed as an others.

Does INTERLAB GmbH have an API?

No public API is recorded for INTERLAB GmbH.

What industry is INTERLAB GmbH in?

INTERLAB GmbH's product category is Contract Laboratory Services. Its primary akta.pro industry code is HLAFAMAL, Clinical Research & Trial Central Laboratories, with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales